Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2020 | Real world use of Radium-233 for mCRPC

Rana McKay • 13 Feb 2020
GU Cancers 2020
Genitourinary Cancer Prostate Cancer Abiraterone Enzalutamide Radium-223 Sipuleucel-T
ALSYMPCA

Rana McKay, MD, University of California, San Diego, CA, discusses the real world utilization of Radium-223 for the treatment of metastatic castrate-resistant prostate cancer (mCRPC). This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

More from Rana McKay

CheckMate 214: patterns of progression with nivolumab plus ipilimumab versus sunitinib for RCC
5:10
CheckMate 214: patterns of progression with nivolumab plus ipilimumab versus sunitinib for RCC
Rana McKay • 17 Feb 2021
Homologous recombination repair pathway alterations in mHSPC
3:53
Homologous recombination repair pathway alterations in mHSPC
Rana McKay • 17 Feb 2021
Biomarker analysis of olaparib with or without cediranib in mCRPC
5:41
Biomarker analysis of olaparib with or without cediranib in mCRPC
Rana McKay • 17 Feb 2021
Neoadjuvant androgen deprivation therapy in men with high-risk localized prostate cancer
11:22
Neoadjuvant androgen deprivation therapy in men with high-risk localized prostate cancer
Rana McKay • 28 May 2020

Related Videos

Current and emerging systemic strategies in biochemically relapsed prostate cancer
2:45
Current and emerging systemic strategies in biochemically relapsed prostate cancer
Ashwin Sachdeva • 16 May 2026
How has SABR improved radiotherapy practice in kidney cancer?
1:06
How has SABR improved radiotherapy practice in kidney cancer?
Shankar Siva • 16 May 2026
Which patients with kidney cancer may benefit from SABR treatment?
1:58
Which patients with kidney cancer may benefit from SABR treatment?
Shankar Siva • 16 May 2026
Management of brain metastasis in patients with poor-risk testicular cancer
1:03
Management of brain metastasis in patients with poor-risk testicular cancer
Darren Feldman • 30 May 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals